CSF-1 |
• ERK1/2 activation, inducing the activation of Ets transcription factors, thus increasing of cyclin-D expression. |
[12,78]. |
• ERK5 activation, downregulation of p21 expression and increased expression of Ets2 and Cyclin-D |
[63] |
• KLF2 and KLF4 upregulation. |
[13] |
• c-myc upregulation. |
[13] |
IL-34 |
• Partially affects TAMs proliferation through its ability to interact with CSF1R. |
[99] |
GM-CSF |
• Activation of JAK2/STAT5 pathway. |
[12,13,14] |
• Activation of Bhlhe40/Bhlhe41 which inhibits c-Maf and Mafb transcription factors, thereby directly promoting expression of transcripts encoding cell cycle-related proteins. |
[107,108] |
ADO-1 |
• Working synergically with GM-CSF causes the upregulaion of PI3K/Akt and MEK/ERK signaling downstream of A2A activation. |
[106] |
• Promotes macrophage proliferation, in part, through the transcriptional regulation of A2A. |
[106] |
IL-4 |
• Induce the transcription of STAT6 and activates PI3K/AKT signaling. |
[12] |
• May stimulate macrophage proliferation in an Akt- and ACLY-dependent manner. |
[109] |